Verana Health

[New White Paper] Read about our work in curating unstructured clinical notes from urology EHRs to generate real-world evidence. Using data on more than 364,000 patients with prostate cancer, we can identify key variables including metastasis, TNM stage, PSA level and more. https://lnkd.in/dMSWW7ri

Did you know claims data is the minimum? For maximum results, you need #EHR data. Learn more about this powerful #RWD source at this link: https://lnkd.in/gCXVpRX5

The FDA's final guidance on the use of #RWD represents a pivotal step forward in leveraging #EHR and claims data for regulatory decision-making. By promoting transparency, reliability, and methodological rigor in studies utilizing EHR data, the FDA facilitates expedited product approvals and enhances the ongoing monitoring of existing products. This promises to foster innovation in medical research and improve patient outcomes through more informed regulatory decisions. https://hubs.la/Q02H-Kn20

[NEW ON OUR BLOG] Our Head of Clinical Trials, Ashley Daigneau, shares how quality #RWE can lead to more effective, efficient and patient-centric trials: https://hubs.la/Q02HM_Dd0

Thank you, Modern Retina, for featuring our Medical Advisor, Theodore Leng, MD, MS, as part of this week's ASRS – American Society of Retina Specialists Meeting coverage. In the video interview, Dr. Leng discusses the FARETINA-DME Study that utilized #RWD we curated from the American Academy of Ophthalmology IRISⓇ Registry (Intelligent Research in Sight) to identify the 12-month real-world outcomes of #faricimab in patients with diabetic macular edema. https://hubs.la/Q02Hdhq20 #ASRS2024 #rwe

Did you know our Qdata UME dataset includes 152K+ de-identified patients and diagnosis information only found in clinical notes of #EHRs? Learn more: https://lnkd.in/gv999Kc9

[NEW ON OUR BLOG] Our SVP of Data & Science, Aracelis Torres, PhD, MPH, explains how the transformation of #RWD into #RWE can help remove barriers to accessing timely and quality healthcare: https://hubs.la/Q02GKcJJ0

Our Medical Advisor, Theodore Leng, MD, MS, will head to Sweden next week to present results from the FARETINA-DME Study at the ASRS Annual Meeting. The study analyzes #RWD from the American Academy of Ophthalmology IRISⓇ Registry (Intelligent Research in Sight) to identify the 12-month real-world clinical and anatomical outcomes with #faricimab in patients with diabetic macular edema. https://hubs.la/Q02G9Fcz0 #DME #rwd #rwe

During a virtual ARVO Special Interest Group meeting tomorrow, our Medical Advisor, Durga S. Borkar, MD, MMCi, will moderate a discussion on "Methodological Considerations for Real-world Data Studies in Ophthalmology." Our Quantitative Sciences Director, Zhongdi Chu, PhD, will be among the panelists. For details, visit: https://hubs.la/Q02G0qGc0

[NEW ON OUR BLOG] Our SVP of Data & Science, Aracelis Torres, PhD, MPH, shares how utilizing #RWD and advanced #AI techniques can provide a more comprehensive view of the safety and effectiveness of #IOLs in young patients with cataracts. Learn about our recent study in partnership with the FDA and the American Academy of Ophthalmology: https://hubs.la/Q02FQGV60